Focus Partners Wealth Portfolio holdings
AUM
$46.1B
1-Year Return
15.84%
This Quarter Return
-1.63%
1 Year Return
+15.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$39.9B
AUM Growth
+$1.42B
(+3.7%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
20.36%
Holding
2,021
New
170
Increased
916
Reduced
729
Closed
139
Top Buys
| 1 |
Avantis US Small Cap Value ETF
AVUV
|
+$341M |
| 2 |
Dimensional US High Profitability ETF
DUHP
|
+$278M |
| 3 |
Dimensional International Small Cap Value ETF
DISV
|
+$272M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$220M |
| 5 |
iShares S&P 100 ETF
OEF
|
+$201M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$76.9M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$40.7M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.2M |
| 4 |
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
|
+$37.5M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$30.6M |
Sector Composition
| 1 | Technology | 12.2% |
| 2 | Financials | 7.29% |
| 3 | Consumer Discretionary | 4.54% |
| 4 | Healthcare | 4.29% |
| 5 | Consumer Staples | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Fate Therapeutics
FATE
$111M
| $23.9K | ﹤0.01% |
30,201
+6,008
| +25% | +$4.75K |
|
1852
Forge Global Holdings
FRGE
$239M
| $23.3K | ﹤0.01% |
2,759
+91
| +3% | +$767 |
|
|
MKZR
1853
MacKenzie Realty Capital, Inc. Common Stock
MKZR
$9.75M
| $22.5K | ﹤0.01% |
1,500
-487
| -25% | -$7.31K |
|
|
EU
1854
enCore Energy
EU
$417M
| $22K | ﹤0.01% |
+16,035
| New | +$22K |
|
1855
Editas Medicine
EDIT
$242M
| $21.8K | ﹤0.01% |
18,750
+6,961
| +59% | +$8.08K |
|
1856
Perfect Corp
PERF
$212M
| $21.3K | ﹤0.01% |
11,375
| – | – |
|
1857
Nerdy
NRDY
$158M
| $21.3K | ﹤0.01% |
14,967
-509
| -3% | -$723 |
|
1858
Akebia Therapeutics
AKBA
$782M
| $21.2K | ﹤0.01% |
11,391
+499
| +5% | +$930 |
|
1859
Immix Biopharma
IMMX
$60.6M
| $20K | ﹤0.01% |
11,900
| – | – |
|
1860
Opko Health
OPK
$1.11B
| $19.1K | ﹤0.01% |
+11,524
| New | +$19.1K |
|
1861
Douglas Elliman
DOUG
$241M
| $18.9K | ﹤0.01% |
+11,000
| New | +$18.9K |
|
1862
Standard BioTools
LAB
$493M
| $16.5K | ﹤0.01% |
15,282
+1,227
| +9% | +$1.33K |
|
1863
Galectin Therapeutics
GALT
$344M
| $16.3K | ﹤0.01% |
13,330
-1,921
| -13% | -$2.34K |
|
1864
Tilray
TLRY
$1.23B
| $15.9K | ﹤0.01% |
24,169
-2,605
| -10% | -$1.71K |
|
1865
GEE Group
JOB
$23M
| $15.2K | ﹤0.01% |
75,084
| – | – |
|
1866
DarioHealth
DRIO
$17.1M
| $14.7K | ﹤0.01% |
1,202
| – | – |
|
1867
GoPro
GPRO
$327M
| $10.9K | ﹤0.01% |
+16,446
| New | +$10.9K |
|
1868
RenovoRx
RNXT
$46.9M
| $10.9K | ﹤0.01% |
+11,000
| New | +$10.9K |
|
1869
Mersana Therapeutics
MRSN
$35.6M
| $10.5K | ﹤0.01% |
+1,221
| New | +$10.5K |
|
1870
Veru
VERU
$50.5M
| $10.5K | ﹤0.01% |
2,133
+13
| +0.6% | +$64 |
|
1871
Sangamo Therapeutics
SGMO
$152M
| $9.38K | ﹤0.01% |
14,300
-900
| -6% | -$590 |
|
1872
Nektar Therapeutics
NKTR
$926M
| $8.79K | ﹤0.01% |
+861
| New | +$8.79K |
|
1873
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $8.76K | ﹤0.01% |
+10,857
| New | +$8.76K |
|
1874
Tenaya Therapeutics
TNYA
$196M
| $6.99K | ﹤0.01% |
+12,263
| New | +$6.99K |
|
|
URG
1875
Ur-Energy
URG
$533M
| $6.96K | ﹤0.01% |
10,324
+324
| +3% | +$218 |
|